These effects were generally dose-dependent, most pronounced during dose escalation, and are consistent with the known side effect profile of approved GLP-1 receptor agonists
Yet the soaring enthusiasm for so-called glucagon-like peptide-1 receptor agonists, first approved in 2005 , overshadows an array of risks related to their off-label use
In the SURMOUNT-1 trial, participants taking Mounjaro showed significant improvements across several mental health measures, including emotional functioning, social interactions, and overall psychological wellbeing, compared to those taking a placebo
If you have insurance coverage for GLP-1 medications, Ro could be significantly cheaper
The cost of Zepbound with Kaiser Permanente varies by insurance plan, but can be as low as $25